| Serial Number | 90642191 |
| Word Mark | XGENE PHARMACEUTICAL |
| Filing Date | Tuesday, April 13, 2021 |
| Status | 733 - FOURTH EXTENSION - GRANTED |
| Status Date | Wednesday, May 14, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, March 28, 2023 |
| Description of Mark | The mark consists of a design consisting of a series of geometric shapes, together forming a hexagon. Beginning at the top of the design and moving counter clockwise, the shapes are a blue triangle, a blue diamond, two green diamonds and a sixth negative space bordered by the letter X in term XGENE, which is at the top right of the design element with the letter X in the colors blue and green, and the letters GENE in the color blue. The green term PHARMACEUTICAL is to the right of the design image and beneath the term XGENE. |
| Goods and Services | Vaccines; Medicines for human purposes, namely, medicines for treatment of cancer; Pharmaceutical preparations for the treatment of viral diseases; Pharmaceutical products for the treatment of cancer; Biological preparations for the treatment of cancer; Pain relief medication; Biological preparations for medical purposes, namely, biological preparations for the treatment of cancer; Antibiotics; Chemico-pharmaceutical preparations for treatment of cancer; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for treating skin disorders; Dermatological pharmaceutical products; Herbicide for agricultural use; Pesticides for agricultural use; Fungicides for agricultural use; Medicines for veterinary purposes, namely, killing insects |
| Indication of Colors claimed | The color(s) blue and green is/are claimed as a feature of the mark. |
| NOT AVAILABLE | "PHARMACEUTICAL" |
| Goods and Services | Chemical research; Chemical analysis; Chemistry consultation; Cosmetic research; Biological research; Scientific research; Scientific research and development; Research and development of new products for others; Medical research; Technological research in the field of medical instruments; Product quality testing; Scientific research for medical purposes in the area of cancerous diseases |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, July 20, 2021 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, July 20, 2021 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | XGENE PHARMACEUTICAL INC. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | GRAND CAYMAN KY1-1205 KY |
| Party Name | XGENE PHARMACEUTICAL INC. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | GRAND CAYMAN KY1-1205 KY |
| Event Date | Event Description |
| Wednesday, July 21, 2021 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Friday, April 16, 2021 | NEW APPLICATION ENTERED |
| Tuesday, July 20, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, December 3, 2021 | ASSIGNED TO EXAMINER |
| Friday, December 3, 2021 | NON-FINAL ACTION WRITTEN |
| Friday, December 3, 2021 | NON-FINAL ACTION E-MAILED |
| Friday, December 3, 2021 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, June 2, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, June 2, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, June 2, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, July 18, 2022 | NON-FINAL ACTION WRITTEN |
| Monday, July 18, 2022 | NON-FINAL ACTION E-MAILED |
| Monday, July 18, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, January 17, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, January 17, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, January 17, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, February 22, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, March 8, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, March 28, 2023 | PUBLISHED FOR OPPOSITION |
| Tuesday, March 28, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, May 23, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Thursday, November 9, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, November 7, 2023 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, November 7, 2023 | SOU EXTENSION 1 FILED |
| Tuesday, November 7, 2023 | SOU EXTENSION 1 GRANTED |
| Wednesday, May 15, 2024 | SOU EXTENSION 2 FILED |
| Wednesday, May 15, 2024 | SOU EXTENSION 2 GRANTED |
| Tuesday, November 12, 2024 | SOU TEAS EXTENSION RECEIVED |
| Monday, December 9, 2024 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Thursday, December 19, 2024 | SOU EXTENSION 3 GRANTED |
| Wednesday, May 15, 2024 | SOU TEAS EXTENSION RECEIVED |
| Thursday, May 16, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, November 12, 2024 | SOU EXTENSION 3 FILED |
| Thursday, December 19, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, May 14, 2025 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, May 14, 2025 | SOU EXTENSION 4 FILED |
| Thursday, May 15, 2025 | SOU EXTENSION 4 GRANTED |
| Thursday, May 15, 2025 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |